Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Russell P Rother
Scott A Rollins
Christopher F Mojcik
Robert A Brodsky
Leonard Bell
机构：
来源：
Nature Biotechnology | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Biotechnol. 25, 1256–1264 (2007); published online 7 November 2007; corrected after print 7 December 2007 In the version of this article initially published, on p. 1258, paragraph 2, the incorrect serum concentrations to reach steady state and the incorrect accumulation ratio (Racc) for eculizumab were given.
引用
收藏
页码：1488 / 1488
相关论文
共 50 条
  • [1] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [2] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [3] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [4] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (vol 25, pg 1256, 2007)
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    NATURE BIOTECHNOLOGY, 2007, 25 (12) : 1488 - 1488
  • [5] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    BLOOD, 2007, 110 (12) : 4123 - 4128
  • [6] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [7] Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
    Brodsky, Robert A.
    Young, Neal S.
    Antonioli, Elisabetta
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Schubert, Jorg
    Gaya, Anna
    Coyle, Luke
    De Castro, Carlos
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw P.
    Bessler, Monica
    Kroon, Henk-Andre
    Rother, Russell P.
    Hillmen, Peter
    BLOOD, 2008, 111 (04) : 1840 - 1847
  • [8] EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED
    Risitano, A.
    Alfinito, F.
    Seneca, E.
    Marando, L.
    Boschetti, C.
    Bonfigli, S.
    Fenu, S.
    Re, F.
    Gosetti, G.
    Khursigara, G.
    Rother, R.
    Zanella, A.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 237 - 237
  • [9] Theterminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P.
    Muus, P.
    Duehrsen, U.
    Risitano, A.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Hill, A.
    Socie, G.
    Bessler, M.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 138
  • [10] Erythropoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria
    Hill, A.
    Richards, S. J.
    Rother, R. P.
    Hillmen, P.
    HAEMATOLOGICA, 2007, 92 (03) : E31 - E33
12345